
Nosylate 500mg/250mg Tablet
Marketer
Gnosis Pharmaceuticals Pvt Ltd
Salt Composition
Tranexamic Acid (500mg) + Ethamsylate (250mg)
Overview Nosylate 500mg/250mg Tablet
Combifem 500mg/250mg tablets are prescribed to manage abnormally heavy menstrual flow. This dual-action medication inhibits clot breakdown, thus curbing excessive bleeding, and enhances platelet aggregation for improved clotting. Dosage timing is flexible—with or without food—but consistency is key; take it at the same time daily as directed by your physician. Continue treatment for the prescribed duration, even if symptoms improve. Missed doses should be taken promptly. Abrupt cessation should be avoided without consulting your doctor. Common side effects include nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is possible; increased fluid intake is recommended to prevent dehydration. If menstrual flow doesn't improve after three cycles, consult your doctor. Prior to starting treatment, inform your doctor of any kidney issues, vaginal bleeding disorders, or pregnancy/breastfeeding status. Disclosure of all other medications is also necessary. Regular eye examinations may be required during treatment.
Primary Ingredients of Nosylate 500mg/250mg Tablet
The provided text is "undefined," offering no content to rephrase.
Uses of Nosylate 500mg/250mg Tablet
Profuse uterine bleeding
Major Benefits of Nosylate 500mg/250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 500mg/250mg Nosylate tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Nosylate 500mg/250mg Tablet:
- Nausea
- Stomach pain
- Diarrhea
- Headache
- Nasal congestion (stuffy nose)
- Sinus pain
- Sinus inflammation
- Rash
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
How to use Nosylate 500mg/250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 500mg/250mg Nosylate tablet can be consumed with or without food, though consistent timing is recommended.
How Nosylate 500mg/250mg Tablet works:
Each 500mg/250mg Nosylate tablet combines tranexamic acid and ethamsylate, two agents that control excessive blood loss. Tranexamic acid, an antifibrinolytic, stabilizes blood clots by inhibiting their breakdown. Ethamsylate, a hemostatic, enhances platelet aggregation and clot formation, thus managing bleeding, particularly from capillaries.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol with a 500mg/250mg nosylate tablet may induce significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of 500mg/250mg Nosylate tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 500mg/250mg Nosylate tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by 500mg/250mg Nosylate tablets.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using 500mg/250mg Nosylate tablets. Dosage modification of 500mg/250mg Nosylate tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The 500mg/250mg Nosylate tablet is likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Nosylate 500mg/250mg Tablet :
Should you forget a Nosylate 500mg/250mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nosylate 500mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
